Meeting Announcement BGI Genomics FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Webinar Posterview more Credit: BGI Genomics On January 21st, the Thalassemia International Federation (TIF) and BGI Genomics jointly hosted an educational webinar focused on thalassemia prevention in high-prevalence regions. The event featured five international experts from four different countries. Experts emphasized that thalassemia is a preventable disease and high-throughput sequencing...
Tag: <span>thalassemia</span>
Enzyme identified as possible novel drug target for sickle cell disease, Thalassemia
July 19, 2018, Children’s Hospital of Philadelphia Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease (SCD). Experiments in cultured human cells reveal that blocking the protein reduces the characteristic sickling that distorts the...
Major breakthrough in the manufacture of red blood cells
Researchers have generated the first immortalised cell lines which allow more efficient manufacture of red blood cells. The team, from the University of Bristol and NHS Blood and Transplant, were able to manufacture red blood cells in a more efficient scale than was previously possible. The results, published in Nature Communications, could, if successfully tested in...